Insider Trading26 Jun 2026, 07:10 pm
Aarti Drugs Closes Trading Window for Q1 FY27 Results
AI Summary
Aarti Drugs Ltd has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 1, 2026, until 48 hours after the declaration of the financial results for the quarter ended June 30, 2026. This measure is standard practice to prevent insider trading during the period leading up to and immediately following the announcement of financial performance.
Key Highlights
- Trading window closed from July 1, 2026.
- Closure is for Q1 FY27 financial results announcement.
- Window reopens 48 hours post-results declaration.
- Aims to prevent insider trading.
- Standard corporate governance practice.
Price Impact
More from AARTIDRUGS